Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CSPC Pharmaceutical Group Ltd

+ Add to Watchlist

1093:HK

6.550 HKD 0.060 0.92%

As of 03:01:04 ET on 01/30/2015.

Snapshot for CSPC Pharmaceutical Group Ltd (1093)

Open: 6.510 Day's Range: 6.480 - 6.640 Volume: 12,573,729
Previous Close: 6.490 52wk Range: 5.320 - 8.490 1-Yr Rtn: +3.16%

Stock Chart for 1093

No chart data available.
  • 1093:HK 6.550
  • 1D
  • 1M
  • 1Y
6.490
Interactive 1093 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 1093

Current P/E Ratio (ttm) 35.6754
Estimated P/E(12/2014) 29.7727
Relative P/E vs. HSI 3.4146
Earnings Per Share (HKD) (ttm) 0.1836
Est. EPS (HKD) (12/2014) 0.2200
Est. PEG Ratio 1.0266
Market Cap (M HKD) 38,697.52
Shares Outstanding (M) 5,908.02
30 Day Average Volume 11,900,130
Price/Book (mrq) 5.2148
Price/Sale (ttm) 3.6868
Dividend Indicated Gross Yield 1.22%
Cash Dividend (HKD) 0.0800
Dividend Ex-Date 05/23/2014
5 Year Dividend Growth -16.74%
Next Earnings Announcement 03/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 1093

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for 1093

CSPC Pharmaceutical Group Limited, through its subsidiaries, manufactures and sells pharmaceutical products. The Company's products include vitamin C, antibiotics and common generic drugs. The Company is also engages in the development of innovative drugs and antibiotics.

Cai DongchenChairman/CEOWang JinxuSenior VP/CTO
Chak Kin ManExecutive DirectorFeng ZhenyingExecutive Director
More Company Profile & Key Executives for 1093

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil